ppk27 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Structure and Function

Antibodies are Y-shaped proteins (immunoglobulins) composed of two heavy chains and two light chains, designed to bind specific epitopes on antigens . Their variable regions (VH/VL domains) determine specificity, while constant regions (CH/CL domains) mediate immune effector functions . For example, monoclonal antibodies like MK-5890 (anti-CD27) and prasinezumab (anti-α-synuclein) demonstrate tailored epitope recognition and therapeutic applications .

Antibodies in Disease Pathways

Several antibodies in the search results target specific disease-associated proteins:

  • CD27 agonist MK-5890: Enhances T-cell activity in cancer immunotherapy, with sub-nanomolar binding affinity and epitope mapping via X-ray crystallography .

  • P2X7 receptor antibody (L4 clone): Used in flow cytometry assays to study receptor expression and function .

  • RSV p27 antibodies: Recognize a cleavage peptide (aa 101–121) of the viral fusion protein, with age-dependent immunodominance in pediatric populations .

Hypothetical "ppk27 Antibody" Considerations

If "ppk27 Antibody" refers to a novel therapeutic or diagnostic antibody:

  • Target identification: It would likely bind a specific protein (e.g., ppk27, a hypothetical variant of ppk301, an ion channel in mosquitoes ).

  • Therapeutic relevance: Could address conditions linked to ppk27 expression, analogous to how anti-α-synuclein antibodies target neurodegenerative diseases .

  • Development challenges: Requires epitope mapping, functional assays (e.g., binding affinity via ELISA), and preclinical validation .

Research Gaps and Recommendations

Given the absence of "ppk27 Antibody" in the search results, future studies could:

  1. Characterize ppk27 protein: Determine its role in cellular processes (e.g., ion transport, signaling).

  2. Develop epitope-specific antibodies: Use phage display or hybridoma techniques to generate high-affinity reagents .

  3. Validate therapeutic potential: Assess efficacy in disease models (e.g., oncology, neurodegeneration) using flow cytometry and in vivo assays .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
ppk27 antibody; SPBC337.04 antibody; Serine/threonine-protein kinase ppk27 antibody; EC 2.7.11.1 antibody
Target Names
ppk27
Uniprot No.

Target Background

Database Links
Protein Families
Protein kinase superfamily, Ser/Thr protein kinase family
Subcellular Location
Cytoplasm.

Q&A

What is ppk27 and why is it important in research?

Ppk27 (serine/threonine-protein kinase ppk27, EC 2.7.11.1) is a protein kinase found in the fission yeast Schizosaccharomyces pombe. It's encoded by the gene SPBC337.04 and is significant in cell signaling pathways . As a serine/threonine kinase, ppk27 plays a potential role in phosphorylation events that regulate various cellular processes. Research on ppk27 contributes to our understanding of kinase-dependent signaling networks in eukaryotic cells, particularly in the context of cell cycle regulation, stress responses, and potentially genome stability in S. pombe .

What methods are available for ppk27 detection in fission yeast?

Multiple methodologies can be employed for detecting ppk27 in fission yeast:

  • Western blotting: The most common approach uses anti-ppk27 antibodies for detection after protein separation by SDS-PAGE. This requires proper sample preparation from S. pombe cells, protein transfer to membranes, and optimization of antibody dilutions .

  • Immunoprecipitation: Anti-ppk27 antibodies can be used in pull-down experiments to isolate ppk27 and its binding partners from yeast cell lysates .

  • Mass spectrometry: For identification and quantification of ppk27 and its post-translational modifications, particularly phosphorylation events .

  • Quantitative PCR: For analyzing ppk27 gene expression levels at the transcript level, though this doesn't detect the protein itself .

For optimal results, researchers should use polyclonal antibodies with verified specificity against S. pombe ppk27, such as rabbit-derived antibodies that recognize multiple epitopes .

How should researchers prepare S. pombe samples for ppk27 antibody detection?

Efficient sample preparation is crucial for ppk27 detection. The following protocol is recommended based on established methods:

Sample preparation protocol:

  • Culture S. pombe cells to mid-log phase (OD600 ≈ 0.5-0.8)

  • Harvest cells by centrifugation (3,000 x g for 5 minutes)

  • Wash cell pellet with cold PBS

  • Resuspend in lysis buffer containing:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 1% Triton X-100

    • 1 mM EDTA

    • Protease inhibitor cocktail

    • Phosphatase inhibitors (critical for preserving phosphorylation status)

  • Disrupt cells using glass beads in a cell disruptor (8 cycles of 30 seconds)

  • Clarify lysate by centrifugation (14,000 x g for 15 minutes at 4°C)

  • Quantify protein concentration using Bradford or BCA assay

For Western blot detection, 20-50 μg of total protein is typically sufficient, while immunoprecipitation experiments may require 200-500 μg of protein .

What are the major challenges in verifying ppk27 antibody specificity and how can researchers overcome them?

Verifying antibody specificity for ppk27 presents several challenges:

Key challenges:

  • Cross-reactivity with other kinases with similar epitopes

  • Variable expression levels of ppk27 across growth conditions

  • Potential post-translational modifications affecting antibody recognition

  • Limited commercial availability of validated anti-ppk27 antibodies for S. pombe

Recommended verification approaches:

  • Genetic controls: Use ppk27 deletion strains (Δppk27) as negative controls to confirm antibody specificity .

  • Epitope-tagged validation: Compare detection between native ppk27 and epitope-tagged versions (e.g., HA, FLAG, or myc-tagged ppk27) .

  • Peptide competition assay: Pre-incubate antibody with purified ppk27 peptide before Western blotting to confirm signal specificity.

  • Multiple antibody validation: Use antibodies targeting different epitopes of ppk27 to confirm detection.

  • Mass spectrometry confirmation: Verify immunoprecipitated proteins by mass spectrometry to confirm ppk27 identity .

For example, in Wang's study, epitope tagging of proteins was performed by PCR-based genomic integration followed by verification using antibodies against both the tag and the native protein to ensure specificity of detection .

How can researchers optimize antibody-based pull-down experiments for ppk27 protein-protein interaction studies?

Optimizing pull-down experiments for ppk27 requires careful consideration of several parameters:

Optimization protocol:

  • Cell lysis optimization:

    • Use cryogenic disruption for efficient lysis of S. pombe cells

    • Employ gentle detergents (0.1-0.5% NP-40 or Triton X-100) to preserve protein complexes

    • Include phosphatase inhibitors to maintain phosphorylation-dependent interactions

  • Antibody selection and immobilization:

    • Use affinity-purified antibodies against ppk27

    • Alternatively, use antibodies against epitope tags if working with tagged ppk27

    • Pre-clear lysates with protein A/G beads to reduce non-specific binding

    • Cross-link antibodies to beads using dimethyl pimelimidate to prevent antibody leaching

  • Binding conditions:

    • Optimize salt concentration (typically 100-150 mM NaCl)

    • Adjust incubation time (2-4 hours at 4°C or overnight)

    • Include BSA (0.1-0.5%) to reduce non-specific binding

  • Washing stringency:

    • Perform 3-5 washes with increasing stringency

    • Analyze both bound fractions and washes to monitor loss of specific interactions

  • Elution strategies:

    • Competitive elution with ppk27 peptide

    • Low pH elution (glycine buffer, pH 2.5-3.0)

    • SDS elution for maximum recovery

  • Controls:

    • IgG control antibodies of the same species

    • Pull-downs from ppk27 deletion strains

    • Pull-downs with competing peptides

This optimized protocol significantly improves the signal-to-noise ratio in ppk27 interaction studies, as demonstrated in co-immunoprecipitation experiments in S. pombe .

What approaches can be used to study ppk27 phosphorylation targets in S. pombe?

Identifying ppk27 phosphorylation targets requires a multi-faceted approach:

Recommended methodologies:

  • In vitro kinase assays:

    • Purify recombinant ppk27 (wild-type and kinase-dead mutants)

    • Incubate with candidate substrates or cell lysate fractions

    • Detect phosphorylation using [γ-32P]ATP or phospho-specific antibodies

    • Analyze by autoradiography or Western blotting

  • Substrate trapping:

    • Generate catalytically inactive ppk27 mutants that bind but don't phosphorylate substrates

    • Perform pull-down experiments followed by mass spectrometry

    • Compare bound proteins between wild-type and substrate-trapping mutants

  • Phosphoproteomics:

    • Compare phosphoproteomes of wild-type and Δppk27 strains

    • Enrich phosphopeptides using TiO2 or immobilized metal affinity chromatography

    • Analyze by LC-MS/MS to identify differentially phosphorylated proteins

    • Look for phosphorylation at S/T residues in consensus motifs

  • Genetic interaction mapping:

    • Perform synthetic genetic array analysis with ppk27 deletion strains

    • Identify genes showing genetic interactions, which may include substrates

  • Bioinformatic prediction and validation:

    • Use algorithms to predict ppk27 phosphorylation sites based on consensus sequences

    • Validate predictions experimentally using site-directed mutagenesis of candidate substrates

This integrated approach has been successful in identifying substrates of other kinases in S. pombe and could be applied to ppk27 .

How can researchers design experiments to study the role of ppk27 in cellular stress responses?

Designing experiments to elucidate ppk27's role in stress responses requires systematic approaches:

Experimental design framework:

  • Gene expression analysis:

    • Monitor ppk27 expression levels under various stress conditions (oxidative, heat, osmotic, nutrient deprivation)

    • Use RT-qPCR or RNA-seq to quantify transcriptional changes

    • Compare with known stress-responsive kinases as positive controls

  • Phenotypic characterization:

    • Generate ppk27 deletion (Δppk27) and overexpression strains

    • Assess growth rates under normal and stress conditions

    • Perform spot assays with serial dilutions on media containing stressors

    • Measure survival rates after acute stress exposure

  • Phosphorylation dynamics:

    • Use phospho-specific antibodies to monitor ppk27 activation under stress

    • Perform time-course experiments to track phosphorylation changes

    • Identify upstream kinases using candidate approach or kinase inhibitors

  • Subcellular localization:

    • Create GFP-tagged ppk27 to track localization changes during stress

    • Use immunofluorescence with anti-ppk27 antibodies as an alternative approach

    • Perform co-localization studies with organelle markers

  • Genetic interaction analysis:

    • Cross Δppk27 with deletion strains of known stress response genes

    • Analyze epistatic relationships to position ppk27 in signaling pathways

    • Perform genome-wide synthetic genetic array analysis

  • Transcriptional targets:

    • Perform RNA-seq comparing wild-type and Δppk27 strains under stress

    • Identify differentially expressed genes regulated by ppk27

This comprehensive approach allows for detailed characterization of ppk27's role in stress response pathways .

What methods can be employed to investigate the relationship between ppk27 and cell cycle regulation?

To investigate ppk27's potential role in cell cycle regulation, researchers should employ the following methodologies:

Experimental approaches:

  • Cell synchronization and kinetics analysis:

    • Synchronize cells using cdc25-22 temperature-sensitive mutants or centrifugal elutriation

    • Collect time-course samples across the cell cycle

    • Analyze ppk27 protein levels and phosphorylation status by Western blotting

    • Monitor cell cycle markers (e.g., Cdc13, Cut2) in parallel

  • Cell cycle-specific phenotypic analysis:

    • Characterize Δppk27 mutant cell morphology using microscopy

    • Measure DNA content using flow cytometry to identify cell cycle arrest points

    • Calculate doubling time and cell size at division

    • Assay for mitotic defects using DAPI staining and anti-tubulin antibodies

  • Genetic interaction studies:

    • Create double mutants with known cell cycle regulators

    • Test synthetic lethality or rescue with cdc mutants

    • Position ppk27 in the cell cycle control network

  • Cell cycle-dependent activity assays:

    • Immunoprecipitate ppk27 from synchronized cells

    • Perform in vitro kinase assays to measure activity changes across the cell cycle

    • Identify cell cycle-specific substrates

  • Substrate identification:

    • Use BioID or proximity labeling techniques to identify interactors in different cell cycle phases

    • Perform phosphoproteomics of synchronized Δppk27 vs. wild-type cells

    • Validate candidates with site-specific phospho-mutants

  • Chemical genetic approaches:

    • Generate analog-sensitive ppk27 mutants (ppk27-as)

    • Use specific inhibitors to acutely inhibit ppk27 at different cell cycle stages

    • Monitor immediate consequences on cell cycle progression

This multi-faceted approach provides comprehensive insights into ppk27's role in cell cycle control .

How do researchers interpret conflicting results in ppk27 antibody-based experiments?

When confronted with conflicting results in ppk27 antibody experiments, researchers should follow this systematic troubleshooting framework:

Troubleshooting protocol:

  • Antibody validation reassessment:

    • Verify antibody specificity using Δppk27 control strains

    • Test multiple antibody batches or sources

    • Perform epitope mapping to confirm recognition sites

    • Evaluate cross-reactivity with related kinases

  • Experimental condition analysis:

    • Create a comparison table of differing experimental conditions:

ParameterExperiment AExperiment BPotential Impact
Cell lysis methodMechanicalChemicalProtein solubility, complex integrity
Buffer compositionLow saltHigh saltInteraction stability, antibody binding
Cell growth phaseLog phaseStationaryExpression levels, phosphorylation status
Detection methodChemiluminescenceFluorescenceSensitivity, quantification accuracy
Antibody dilution1:10001:5000Signal intensity, background
  • Post-translational modification considerations:

    • Test if phosphorylation affects antibody recognition

    • Use phosphatase treatment of samples to standardize phosphorylation status

    • Consider other modifications (e.g., ubiquitination) that might mask epitopes

  • Reproducing conflicting conditions:

    • Systematically test each variable individually

    • Document all parameters meticulously

    • Use positive controls to validate each experimental condition

  • Alternative method validation:

    • Confirm key findings with orthogonal techniques (e.g., mass spectrometry)

    • Use epitope-tagged ppk27 as an alternative detection strategy

    • Consider in vitro translation of ppk27 as a controlled standard

  • Biological variability assessment:

    • Evaluate strain background differences

    • Consider environmental conditions affecting ppk27 expression

    • Test different growth media and stress conditions

This systematic approach helps resolve conflicting results and enhances experimental reproducibility .

What techniques can be used to study ppk27 in relation to genomic stability in S. pombe?

Investigating ppk27's potential role in genomic stability requires specialized techniques:

Methodological approaches:

  • DNA damage response assays:

    • Compare survival of wild-type and Δppk27 strains after exposure to DNA-damaging agents (UV, MMS, hydroxyurea, cisplatin)

    • Perform epistasis analysis with known DNA damage response genes (rad3, chk1, cds1)

    • Monitor checkpoint activation by assessing Chk1 phosphorylation in Δppk27 strains

    • Measure DNA repair efficiency using repair reporter assays

  • Chromosome stability assessment:

    • Quantify chromosome loss rates using adenine color sectoring assays

    • Measure mitotic recombination frequencies

    • Analyze telomere length by Southern blotting

    • Perform pulsed-field gel electrophoresis to detect chromosome fragmentation

  • Replication dynamics:

    • Monitor DNA replication using BrdU incorporation assays

    • Analyze replication fork progression by DNA combing

    • Detect stalled replication forks using γH2A.X staining

    • Study ppk27 localization during S phase

  • Genetic interactions with replication and repair machinery:

    • Create double mutants with key DNA replication factors

    • Test genetic interactions with components of different repair pathways

    • Screen for synthetic lethality with replication checkpoint genes

  • Chromatin structure analysis:

    • Perform chromatin immunoprecipitation to study ppk27 association with chromatin

    • Analyze histone modifications in Δppk27 mutants

    • Assess nucleosome positioning by MNase sensitivity assays

This comprehensive approach enables detailed characterization of ppk27's role in maintaining genomic stability, similar to studies performed with other kinases in S. pombe .

How can researchers develop and validate phospho-specific antibodies for ppk27?

Developing phospho-specific antibodies for ppk27 requires a systematic approach:

Development and validation protocol:

  • Phosphorylation site identification:

    • Perform in silico analysis to predict potential phosphorylation sites

    • Use mass spectrometry to identify actual phosphorylation sites in vivo

    • Focus on conserved residues with functional significance

  • Phosphopeptide design:

    • Synthesize phosphopeptides (10-15 amino acids) containing the phosphorylated residue

    • Include a terminal cysteine for conjugation to carrier proteins

    • Consider synthesizing both phosphorylated and non-phosphorylated versions

  • Immunization strategy:

    • Conjugate phosphopeptides to KLH or BSA carriers

    • Immunize rabbits with phosphopeptide conjugates

    • Boost at appropriate intervals to maximize antibody production

  • Antibody purification:

    • Purify serum using protein A/G chromatography

    • Perform affinity purification using phosphopeptide columns

    • Remove antibodies recognizing non-phosphorylated epitopes using non-phosphopeptide columns

  • Validation approaches:

    • Test specificity using Western blots with phosphatase-treated samples

    • Validate with phospho-mimetic (S/T to E/D) and phospho-dead (S/T to A) mutants

    • Confirm recognition of phosphorylated ppk27 from cells under conditions known to induce phosphorylation

    • Perform peptide competition assays with phospho and non-phospho peptides

  • Cross-reactivity assessment:

    • Test against related kinases with similar phosphorylation motifs

    • Evaluate specificity across different experimental conditions

    • Perform immunoprecipitation followed by mass spectrometry to confirm specificity

This methodical approach ensures development of highly specific phospho-antibodies for studying ppk27 regulation and function .

What are the current limitations in ppk27 research and how might they be addressed in future studies?

The field of ppk27 research faces several challenges that require innovative approaches:

Current limitations and future directions:

  • Limited functional characterization:

    • Current limitation: Incomplete understanding of ppk27's physiological substrates and pathways.

    • Future approach: Implement BioID or proximity labeling techniques to identify interaction partners in their native cellular context.

  • Technical challenges in protein detection:

    • Current limitation: Difficulties in developing specific antibodies for native ppk27.

    • Future approach: Apply CRISPR-Cas9 genome editing to tag endogenous ppk27 at either terminus while maintaining functionality.

  • Redundancy with other kinases:

    • Current limitation: Potential functional overlap with related kinases masking phenotypes.

    • Future approach: Generate multiple kinase deletion strains and apply chemical genetics using analog-sensitive mutants for temporal control.

  • Substrate identification:

    • Current limitation: Challenges in distinguishing direct from indirect substrates.

    • Future approach: Implement phosphoproteomics combined with substrate consensus motif analysis and in vitro validation.

  • Pathway positioning:

    • Current limitation: Unclear position of ppk27 in signaling networks.

    • Future approach: Systematic epistasis analysis with known pathway components and phosphorylation site mapping.

  • Translational relevance:

    • Current limitation: Unknown conservation of function in higher eukaryotes.

    • Future approach: Complementation studies with mammalian orthologs and comparative pathway analysis.

  • Proposed experimental framework for addressing gaps:

Research GapShort-term ApproachLong-term Strategy
Substrate identificationPhosphoproteomics comparing WT vs. Δppk27Develop consensus motif and substrate prediction algorithms
Signaling pathwayTargeted epistasis with known kinasesGenome-wide genetic interaction mapping
Regulatory mechanismsMap phosphorylation sites on ppk27Resolve structure of ppk27 with activators/inhibitors
Physiological functionPhenotypic analysis under diverse conditionsDevelop condition-specific activity sensors

These approaches will address current limitations and advance our understanding of ppk27's functions in cellular processes .

What are the recommended protocols for membrane stripping and reprobing when working with ppk27 antibodies?

When working with ppk27 antibodies in Western blotting experiments, optimized stripping and reprobing protocols are essential:

Recommended stripping protocol:

  • Mild stripping procedure (preferred for ppk27 detection):

    • Wash the membrane in PBS or TBS for 5 minutes to remove ECL substrate

    • Incubate membrane in stripping buffer (0.1M glycine, 0.1% SDS, 1% Tween 20, pH 2.2) for 10 minutes at room temperature

    • Repeat with fresh stripping buffer for another 10 minutes

    • Wash membrane with PBS or TBS (3 × 5 minutes)

    • Re-block membrane before next antibody incubation

  • Harsh stripping procedure (for difficult-to-remove antibodies):

    • Incubate membrane in harsh stripping buffer (62.5 mM Tris-HCl, 2% SDS, 0.7% β-mercaptoethanol, pH 6.7) at 50°C for 5-10 minutes

    • Wash extensively with PBS or TBS (6 × 5 minutes)

    • Re-block membrane thoroughly before next antibody incubation

  • Commercial stripping buffer option:

    • Use Restore PLUS Western Blot Stripping Buffer as directed

    • Incubate for 5-15 minutes at 37°C with gentle shaking

    • Wash thoroughly with TBS or PBS (2 × 5 minutes)

    • Re-block membrane before next antibody application

  • Validation of stripping efficiency:

    • Incubate stripped membrane with ECL substrate and expose to confirm absence of signal

    • If signal persists, repeat stripping procedure

    • For multiplex detection, consider fluorescent secondary antibodies instead of stripping

This optimized protocol minimizes epitope damage while ensuring complete removal of previous antibodies, critical for sequential detection of ppk27 and its post-translational modifications or interaction partners .

What controls should be included in ppk27 localization studies using immunofluorescence?

Robust immunofluorescence studies of ppk27 localization require comprehensive controls:

Essential controls for immunofluorescence:

  • Genetic controls:

    • Δppk27 deletion strain as negative control

    • Overexpression strain as positive control

    • Epitope-tagged ppk27 strain for antibody validation

  • Antibody specificity controls:

    • Primary antibody omission control

    • Isotype-matched irrelevant antibody control

    • Peptide competition assay (pre-incubate antibody with immunizing ppk27 peptide)

    • Multiple antibodies targeting different ppk27 epitopes

  • Signal verification controls:

    • Low ppk27-expressing cells vs. high ppk27-expressing cells

    • Cell cycle-dependent localization controls (if relevant)

    • Co-localization with known markers of subcellular compartments

    • Comparison of fixed vs. live cell imaging (for GFP-tagged ppk27)

  • Technical controls:

    • Autofluorescence control (no antibody)

    • Secondary antibody-only control

    • Fixed but non-permeabilized cells to confirm intracellular staining

  • Biological validation:

    • Stimulus-dependent relocalization (if expected)

    • Mutant forms with altered localization (e.g., NLS or NES mutants)

    • Co-localization with known interaction partners

  • Sample preparation controls:

    • Different fixation methods (paraformaldehyde, methanol)

    • Various permeabilization reagents (Triton X-100, saponin)

    • Antigen retrieval assessment

How can researchers optimize co-immunoprecipitation protocols specifically for detecting ppk27 interactions with other proteins?

Optimizing co-immunoprecipitation (co-IP) protocols for ppk27 requires addressing several critical parameters:

Optimized co-IP protocol for ppk27:

  • Cell lysis optimization:

    • Use gentle lysis buffers to preserve protein-protein interactions:

      • Base buffer: 50 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM DTT

      • Detergent options: 0.5% NP-40 or 0.2% Triton X-100 (test both)

      • Protease inhibitor cocktail (freshly added)

      • Phosphatase inhibitors (10 mM NaF, 1 mM Na3VO4, 50 mM β-glycerophosphate)

    • Optimize cell disruption method (cryogenic grinding for yeast cells)

    • Clarify lysate at 14,000 × g for 15 minutes at 4°C

  • Pre-clearing optimization:

    • Pre-clear lysate with Protein A/G beads (30 μl beads per 1 ml lysate)

    • Incubate for 1 hour at 4°C with rotation

    • Remove beads by centrifugation (1,000 × g for 1 minute)

  • Antibody binding parameters:

    • Test different antibody amounts (2-5 μg per 500 μg protein lysate)

    • Optimize incubation time (2 hours vs. overnight at 4°C)

    • Compare direct antibody addition vs. pre-binding to beads

    • Test crosslinking antibody to beads to prevent antibody contamination in eluates

  • Washing optimization:

    • Test washing buffer stringency:

      • Low stringency: Lysis buffer

      • Medium stringency: Lysis buffer with 250 mM NaCl

      • High stringency: Lysis buffer with 300 mM NaCl or 0.1% SDS

    • Optimize number of washes (3-5 washes)

    • Compare quick vs. extended washes (1 minute vs. 5 minutes)

  • Elution strategy comparison:

    • Denaturing: 1× SDS sample buffer at 95°C for 5 minutes

    • Native: Excess competing peptide

    • Acidic: 0.1 M glycine (pH 2.5) followed by immediate neutralization

  • Detection optimization:

    • Test sample loading amounts (25-100% of IP)

    • Optimize transfer conditions for efficient transfer of interacting proteins

    • Consider gradient gels for detecting interactions with proteins of various sizes

  • Controls:

    • Input control (5% of starting material)

    • IgG control (same species as ppk27 antibody)

    • Δppk27 strain control

    • Reciprocal IP with antibodies against suspected interactors

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.